← Open Payments lookup

RANJANA VERMA: Open Payments

NPI 1144243783 · ABERDEEN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$670 in 26 payments from 12 companies in 2025. Trend: 2023 $423 · 2024 $656 · 2025 $670

Food & beverage: $670
CompanyPaymentsAmount
Alkermes, Inc.3$142
Teva Pharmaceuticals USA, Inc.6$139
Janssen Pharmaceuticals, Inc2$74
Supernus Pharmaceuticals, Inc.4$72
E.R. Squibb & Sons, L.L.C.2$60
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$52
Tris Pharma Inc2$33
Otsuka America Pharmaceutical, Inc.1$27
Collegium Pharmaceutical, Inc.1$25
Vanda Pharmaceuticals Inc.1$22

Products named: UZEDY, LYBALVI, SPRAVATO, Qelbree, COBENFY, CAPLYTA, ARISTADA, AUSTEDO XR.

Industry payments across MD — which companies pay providers there.